Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.87 Analyst target: $11.00 Upside: 1163.79%
Allarity Therapeutics A / S develops various therapeutic candidates for the treatment of cancer using complementary drug-specific diagnostics (cDx) generated by its drug response prediction technology. The company is headquartered in Horsholm, Denmark.
See the full interactive analysis & chart →Informational only — not investment advice.